{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:29:46Z","timestamp":1789378186291,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s11910-996-0041-8","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T22:36:47Z","timestamp":1180132607000},"page":"169-176","source":"Crossref","is-referenced-by-count":56,"title":["Excessive daytime sleepiness and unintended sleep in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"6","author":[{"given":"David B.","family":"Rye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"41_CR1","first-page":"855","volume-title":"Movement Disorders: Neurologic Principles and Practice","author":"D Rye","year":"2004","unstructured":"Rye D, Bliwise D: Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. InMovement Disorders: Neurologic Principles and Practice, edn 2. Edited by Watts R, Koller W. New York: McGraw-Hill; 2004:855\u2013890.","edition":"edn 2"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","volume":"9","author":"DB Rye","year":"2000","unstructured":"Rye DB, Bliwise DL, Dihenia B, Gurecki P: FAST TRACK: daytime sleepiness in Parkinson\u2019s disease. J Sleep Res 2000, 9:63\u201369. First objective documentation of sleepiness and a narcolepsy-like phenotype in PD.","journal-title":"J Sleep Res"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"I Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Andreu M, et al.: Parkinson\u2019s disease a sleepiness: an integral part of PD. Neurology 2002, 58:1019\u20131024. First confirmation and extension of the objective findings of sleepiness and a narcolepsy-like phenotype in PD.","journal-title":"Neurology"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","volume":"52","author":"S Frucht","year":"1999","unstructured":"Frucht S, Rogers J, Greene P, Gordon M, Fahn S, et al.: Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908\u20131910.","journal-title":"Neurology"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1385\/1-59259-326-7:527","volume-title":"Mental and Behavioral Dysfunction in Movement Disorders","author":"D Rye","year":"2003","unstructured":"Rye D, Daley J, Freeman A, Bliwise D: Daytime sleepiness and sleep attacks in idiopathic Parkinson\u2019s Disease. In Mental and Behavioral Dysfunction in Movement Disorders. Edited by Bedard M-A, Agid Y, Chouinard S, et al. Totawa, NJ: Humana Press; 2003:527\u2013538."},{"issue":"8","key":"41_CR6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.63.8_suppl_3.S24","volume":"63","author":"A Schapira","year":"2004","unstructured":"Schapira A: Excessive daytime sleepiness in Parkinson\u2019s disease. Neurology 2004, 63(8 Suppl 3):S24-S27.","journal-title":"Neurology"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2005.01.001","volume":"9","author":"I Arnulf","year":"2005","unstructured":"Arnulf I: Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005, 9:185\u2013200. An excellent and complete review of sleepiness in PD and atypical PD.","journal-title":"Sleep Med Rev"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","volume":"287","author":"DE Hobson","year":"2002","unstructured":"Hobson DE, Lang AE, Martin WR, et al.: Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 2002, 287:455\u2013463. A large survey of the frequency, subjective assessment, clinical correlates, and relevance of PD-related sleepiness to driving.","journal-title":"JAMA"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.465","volume":"58","author":"EK Tan","year":"2002","unstructured":"Tan EK, Lum SY, Fook-Chong SM, et al.: Evaluation of somnolence in Parkinson\u2019s disease: comparison with age and sex matched controls. Neurology 2002, 58:465\u2013468.","journal-title":"Neurology"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.10429","volume":"18","author":"M Brodsky","year":"2003","unstructured":"Brodsky M, Godbold J, Roth T, Olanow C: Sleepiness in Parkinson\u2019s disease: a controlled study. Mov Disord 2003, 18:668\u2013672.","journal-title":"Mov Disord"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.57.8.1392","volume":"57","author":"WG Ondo","year":"2001","unstructured":"Ondo WG, Vuong KV, Khan H, et al.: Daytime sleepiness and other sleep disorders in Parkinson\u2019s disease. Neurology 2001, 57:1392\u20131396.","journal-title":"Neurology"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1353-8020(00)00076-6","volume":"7","author":"CC Sanjiv","year":"2001","unstructured":"Sanjiv CC, Schulzer M, Mak E, et al.: Daytime somnolence in patients with Parkinson\u2019s disease. Park Rel Disord 2001, 7:283\u2013286.","journal-title":"Park Rel Disord"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archneur.59.6.986","volume":"59","author":"PE O\u2019Suilleabhain","year":"2002","unstructured":"O\u2019Suilleabhain PE, Dewey RB: Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002, 59:986\u2013989.","journal-title":"Arch Neurol"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7","volume":"14","author":"E Tandberg","year":"1999","unstructured":"Tandberg E, Larsen J, Karlsen K: Excessive daytime sleepiness and sleep benefit in Parkinson\u2019s disease: a community based study. Mov Disord 1999, 14:922\u2013927.","journal-title":"Mov Disord"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.58.10.1544","volume":"58","author":"MD Gjerstad","year":"2002","unstructured":"Gjerstad MD, Aarsland D, Larsen JP: Development of daytime somnolence over time in Parkinson\u2019s disease. Neurology 2002, 58:1544\u20131546.","journal-title":"Neurology"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002826-200105000-00013","volume":"24","author":"JL Montastruc","year":"2001","unstructured":"Montastruc JL, Brefel-Courbon C, Senard JM, et al.: Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol 2001, 24:181\u2013183.","journal-title":"Clin Neuropharmacol"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.10167","volume":"17","author":"S Kumar","year":"2002","unstructured":"Kumar S, Bhatia M, Behari M: Sleep disorders in Parkinson\u2019s disease. Mov Disord 2002, 17:775\u2013781.","journal-title":"Mov Disord"},{"key":"41_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.61.1.97","volume":"61","author":"A Razmy","year":"2004","unstructured":"Razmy A, Lang A, Shapiro C: Predictors of impaired daytime sleep and wakefulness in patients with Parkinsons disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004, 61:97\u2013102. A detailed objective assessment of sleepiness and alterness in PD and and their clinical correlates.","journal-title":"Arch Neurol"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/sleep\/27.5.967","volume":"27","author":"S Stevens","year":"2004","unstructured":"Stevens S, Comella C, Stepanski E: Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 2004, 27:967\u2013972.","journal-title":"Sleep"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-005-0614-5","volume":"252","author":"C Baumann","year":"2005","unstructured":"Baumann C, Ferini-Strambi L, Waldvogel D, et al.: Parkinsonism with excessive daytime sleepiness-a narcolepsy like disorder? J Neurol 2005, 252:139\u2013145.","journal-title":"J Neurol"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1389-9457(03)00058-3","volume":"4","author":"T Roth","year":"2003","unstructured":"Roth T, Rye D, Borchert L, et al.: Assessment of sleepiness and unintended sleep in Parkinson\u2019s disease patients taking dopamine agonists. Sleep Med 2003, 4:275\u2013280. Objective demonstration that unintended sleep in sleepy PD patients on dopamine agonists lacks a distinctive \"fingerprint\" by objective sleep laboratory testing.","journal-title":"Sleep Med"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2004.00971.x","volume":"12","author":"D Kaynak","year":"2005","unstructured":"Kaynak D, Kiziltan G, Kaynak H, et al.: Sleep and sleepiness in patients with Parkinson\u2019s disease before and after dopaminergic treatment. Eur J Neurol 2005, 12:199\u2013207.","journal-title":"Eur J Neurol"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.58.3.462","volume":"58","author":"M Ulivelli","year":"2002","unstructured":"Ulivelli M, Rossi S, Lombard C, et al.: Polysomnographic characterization of pergolide-induced \"sleep attacks\" in an idiopathic PD patient. Neurology 2002, 58:462\u2013465.","journal-title":"Neurology"},{"key":"41_CR24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.sleep.2003.01.001","volume":"5","author":"R Manni","year":"2004","unstructured":"Manni R, Terzaghi M, Sartori I, et al.: Dopamine agonists and sleepiness in PD: a review of the literature and personal findings. Sleep Med 2004, 5:189\u2013193.","journal-title":"Sleep Med"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10072-003-0127-x","volume":"24","author":"C Pacchetti","year":"2003","unstructured":"Pacchetti C, Martignoni E, Terzaghi M, et al.: Sleep attacks in Parkinson\u2019s disease: a clinical and polysomnographic study. Neurol Sci 2003, 24:195\u2013196.","journal-title":"Neurol Sci"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","volume":"337","author":"Y Agid","year":"1991","unstructured":"Agid Y: Parkinson\u2019s disease: pathophysiology. Lancet 1991, 337:1321\u20131324.","journal-title":"Lancet"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.53.8.1868","volume":"53","author":"D Rye","year":"1999","unstructured":"Rye D, Johnston L, Watts R, Bliwise D: Juvenile Parkinson\u2019s disease with REM behavior disorder, sleepiness and daytime REM-onsets. Neurology 1999, 53:1868\u20131870.","journal-title":"Neurology"},{"key":"41_CR28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(01)03402-3","volume":"928","author":"M Sakata","year":"2002","unstructured":"Sakata M, Sei H, Toida K, et al.: Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation. Brain Res 2002, 928:194\u2013201.","journal-title":"Brain Res"},{"key":"41_CR29","first-page":"1514","volume":"26","author":"M Decker","year":"2000","unstructured":"Decker M, Keating G, Freeman A, Rye D: Parkinsonian-like sleep-wake architecture in rats with bilateral striatal 6-OHDA lesions. Soc Neurosci Abstracts 2000, 26:1514.","journal-title":"Soc Neurosci Abstracts"},{"key":"41_CR30","first-page":"S218","volume":"22","author":"J Daley","year":"1999","unstructured":"Daley J, Turner R, Bliwise D, Rye D: Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 1999, 22(Suppl):S218-S219.","journal-title":"Sleep"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1212\/WNL.56.12.1616","volume":"56","author":"MH Silber","year":"2001","unstructured":"Silber MH, Rye DB: Solving the mysteries of narcolepsy. Neurology 2001, 56:1616\u20131618.","journal-title":"Neurology"},{"key":"41_CR32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1476-5381.1988.tb11715.x","volume":"95","author":"G Bagetta","year":"1988","unstructured":"Bagetta G, Sarro GD, Priolo E, Nistic\u00f3 G: Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioral and electrocortical sleep in rats. Br J Pharmacol 1988, 95:860\u2013866.","journal-title":"Br J Pharmacol"},{"key":"41_CR33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0306-4522(99)00271-7","volume":"93","author":"C Berridge","year":"1999","unstructured":"Berridge C, O\u2019Neil J, Wifler K: Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience 1999, 93:885\u2013896.","journal-title":"Neuroscience"},{"key":"41_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"K Jellinger","year":"1991","unstructured":"Jellinger K: Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991, 14:153\u2013197.","journal-title":"Mol Chem Neuropathol"},{"key":"41_CR35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.498","volume":"58","author":"S Overeem","year":"2002","unstructured":"Overeem S, van Hilten JJ, Ripley B, et al.: Normal hypocretin-1 levels in Parkinson\u2019s disease patients with excessive daytime sleepiness. Neurology 2002, 58:465\u2013468.","journal-title":"Neurology"},{"key":"41_CR36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","volume":"61","author":"X Drouot","year":"2003","unstructured":"Drouot X, Moutereau S, Nguyen J, et al.: Low levels of ventricular CSF orexin\/hypocretin in advanced PD. Neurology 2003, 61:540\u2013543.","journal-title":"Neurology"},{"key":"41_CR37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/20.9.757","volume":"20","author":"D Rye","year":"1997","unstructured":"Rye D: Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997, 20:757\u2013788.","journal-title":"Sleep"},{"key":"41_CR38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/sleep\/27.4.733","volume":"27","author":"B Frauscher","year":"2004","unstructured":"Frauscher B, Hogl B, Maret S, et al.: Association of daytime sleepiness with COMT polymorphism in patients with parkinson disease: a pilot study. Sleep 2004, 27:733\u2013736.","journal-title":"Sleep"},{"key":"41_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.20134","volume":"19","author":"S Paus","year":"2004","unstructured":"Paus S, Seeger G, Brecht H, et al.: Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson\u2019s disease. Mov Disord 2004, 19:507\u2013509.","journal-title":"Mov Disord"},{"key":"41_CR40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/sleep\/28.7.871","volume":"28","author":"I Rissling","year":"2005","unstructured":"Rissling I, Korner Y, Geller F, et al.: Preprohypocretin polymorphisms in Parkinson disease patients reporting \"sleep attacks\". Sleep 2005, 28:871\u2013875.","journal-title":"Sleep"},{"key":"41_CR41","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","volume":"65","author":"R Abbott","year":"2005","unstructured":"Abbott R, Ross G, White L, et al.: Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005, 65:1442\u20131446.","journal-title":"Neurology"},{"key":"41_CR42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1212\/WNL.54.1.274","volume":"54","author":"S Frucht","year":"2000","unstructured":"Frucht S, Rogers J, Greene P, et al.: Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole [letters to the editor]. Neurology 2000, 54:274\u2013277.","journal-title":"Neurology"},{"key":"41_CR43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6","volume":"15","author":"CW Olanow","year":"2000","unstructured":"Olanow CW, Schapira AH, Roth T: Waking up to sleep episodes in Parkinson\u2019s disease. Mov Disord 2000, 15:212\u2013215.","journal-title":"Mov Disord"},{"key":"41_CR44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1592\/phco.20.7.724.35181","volume":"20","author":"M Ryan","year":"2000","unstructured":"Ryan M, Slevin J, Wells A: Non-ergot dopamine agonistinduced sleep attacks. Pharmacotherapy 2000, 20:724\u2013726.","journal-title":"Pharmacotherapy"},{"key":"41_CR45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N","volume":"15","author":"RA Hauser","year":"2000","unstructured":"Hauser RA, Gauger L, Anderson WM, Zesiewicz TA: Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000, 15:658\u2013663.","journal-title":"Mov Disord"},{"key":"41_CR46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(00)02119-X","volume":"355","author":"J Ferreira","year":"2000","unstructured":"Ferreira J, Galitzky M, Montastruc J, Rascol O: Sleep attacks and Parkinson\u2019s disease treatment. Lancet 2000, 355:1333\u20131334.","journal-title":"Lancet"},{"key":"41_CR47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1472-8206.2003.00120.x","volume":"17","author":"M Bares","year":"2003","unstructured":"Bares M, Kanovsky P, Rektor I: Excessive daytime sleepiness and \u2018sleep attacks\u2019 induced by entacapone. Fundam Clin Pharmacol 2003, 17:113\u2013116.","journal-title":"Fundam Clin Pharmacol"},{"key":"41_CR48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.1083","volume":"16","author":"F Tracik","year":"2001","unstructured":"Tracik F, Ebersbach G: Sudden daytime sleep onset in Parkinson\u2019s disease: polysomnographic recordings. Mov Disord 2001, 16:500\u2013506.","journal-title":"Mov Disord"},{"key":"41_CR49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.10020","volume":"17","author":"JC Moller","year":"2002","unstructured":"Moller JC, Stiasny K, Hargutt V, et al.: Evaluation of sleep and driving performance in six patients with Parkinson\u2019s disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord 2002, 17:474\u2013481.","journal-title":"Mov Disord"},{"key":"41_CR50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00002826-200305000-00003","volume":"26","author":"M Contin","year":"2003","unstructured":"Contin M, Provini F, Martinelli P, et al.: Excessive daytime sleepiness and levodopa in Parkinson\u2019s disease: polygraphic, placebo-controlled monitoring. Clin Neuropharmacol 2003, 26:115\u2013118.","journal-title":"Clin Neuropharmacol"},{"key":"41_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002826-199901000-00004","volume":"22","author":"N Andreau","year":"1999","unstructured":"Andreau N, Chale J, Senard J, et al.: L-dopa induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999, 22:15\u201323.","journal-title":"Clin Neuropharmacol"},{"key":"41_CR52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/WNL.58.3.460","volume":"58","author":"JJ Ferreira","year":"2002","unstructured":"Ferreira JJ, Galitzky M, Thalamas C, et al.: Effect of ropinirole on sleep onset: a randomized placebo controlled study in healthy volunteers. Neurology 2002, 58:460\u2013462.","journal-title":"Neurology"},{"issue":"8","key":"41_CR53","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.63.8_suppl_3.S21","volume":"63","author":"J Santamaria","year":"2004","unstructured":"Santamaria J: How to evaluate excessive daytime sleepiness in Parkinson\u2019s disease. Neurology 2004, 63(8 Suppl 3):S21-S23.","journal-title":"Neurology"},{"key":"41_CR54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.10193","volume":"17","author":"G Fabbrini","year":"2002","unstructured":"Fabbrini G, Barbanti P, Aurilia C, et al.: Excessive daytime sleepiness in de novo and treated Parkinson\u2019s disease. Mov Disord 2002, 17:1026\u20131030.","journal-title":"Mov Disord"},{"key":"41_CR55","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/mds.20412","volume":"20","author":"C Meindorfner","year":"2005","unstructured":"Meindorfner C, Korner Y, Moller J, et al.: Driving in Parkinson\u2019s disease: mobility, accidents, and suddern onset of sleep at the wheel. Mov Disord 2005, 20:832\u2013842.","journal-title":"Mov Disord"},{"key":"41_CR56","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000058905.71369.97","volume":"60","author":"M Merino-Andreu","year":"2003","unstructured":"Merino-Andreu M, Arnulf I, Konofal E, et al.: Unawareness of naps in Parkinson\u2019s disease and in disorders with excessive daytime sleepiness. Neurology 2003, 60:1553\u20131554.","journal-title":"Neurology"},{"key":"41_CR57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/20.8.608","volume":"20","author":"T Young","year":"1997","unstructured":"Young T, Blustein J, Finn L, Palta M: Sleep-disordered breathing and motor vehicle accidents in a population-based sampel of employed adults. Sleep 1997, 20:608\u2013613.","journal-title":"Sleep"},{"key":"41_CR58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10072-003-0114-2","volume":"24","author":"P Dotto Del","year":"2003","unstructured":"Del Dotto P, Gambaccini G, Caneparo D, et al.: Bedtime cabergoline in Parkinson\u2019s disease patients with excessive daytime sleepiness induced by dopamine agonists. Neurol Sci 2003, 24:170\u2013171.","journal-title":"Neurol Sci"},{"key":"41_CR59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1353-8020(00)00035-3","volume":"7","author":"A Rabinstein","year":"2001","unstructured":"Rabinstein A, Shulman LM, Weiner WJ: Modafinil for the treatment of excessive daytime sleepiness in Parkinson\u2019s disease: a case report. Park Rel Disord 2001, 7:287\u2013288.","journal-title":"Park Rel Disord"},{"key":"41_CR60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","volume":"25","author":"AV Nieves","year":"2002","unstructured":"Nieves AV, Lang AE: Treatment off excessive daytime sleepiness in patients with Parkinson\u2019s disease with modafinil. Clin Neuropharmacol 2002, 25:111\u2013114.","journal-title":"Clin Neuropharmacol"},{"key":"41_CR61","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/1531-8257(200011)15:6<1269::AID-MDS1036>3.0.CO;2-R","volume":"15","author":"RA Hauser","year":"2000","unstructured":"Hauser RA, Wahba MN, Zesiewicz TA, Anderson WM: Modafinil treatment of pramipexole-associated somnolence. Mov Disord 2000, 15:1269\u20131271.","journal-title":"Mov Disord"},{"key":"41_CR62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s004150170148","volume":"248","author":"S Happe","year":"2001","unstructured":"Happe S, Pirker W, Sauter C, et al.: Successful treatment of excessive daytime sleepiness in Parkinson\u2019s disease with modafinil. J Neurol 2001, 248:632\u2013634.","journal-title":"J Neurol"},{"key":"41_CR63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","volume":"18","author":"C Adler","year":"2003","unstructured":"Adler C, Caviness J, Hentz J, et al.: Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson\u2019s disease. Mov Disord 2003, 18:287\u2013293.","journal-title":"Mov Disord"},{"key":"41_CR64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","volume":"25","author":"B Hogl","year":"2002","unstructured":"Hogl B, Saletu M, Brandauer E, et al.: Modafinil for the treatment of daytime sleepiness in Parkinson\u2019s disease: double-blind, randomized, cross-over, placebo-controlled polygraph trial. Sleep 2002, 25:905\u2013909.","journal-title":"Sleep"},{"key":"41_CR65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","volume":"11","author":"B Cooper","year":"1994","unstructured":"Cooper B, Wang C, Cox R, et al.: Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 1994, 11:133\u2013141.","journal-title":"Neuropsychopharmacology"},{"key":"41_CR66","first-page":"2657","volume":"73","author":"E Miller","year":"1973","unstructured":"Miller E, Nieburg H: Amphetamines. Valuable adjunct in treatment of Parkinsonism. NY State J Med 1973, 73:2657\u20132661.","journal-title":"NY State J Med"},{"key":"41_CR67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.38.3.232","volume":"38","author":"JD Parkes","year":"1975","unstructured":"Parkes JD, Tarsy D, Marsden CD, et al.: Amphetamines in the treatment of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1975, 38:232\u2013237.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"41_CR68","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.50.5.1332","volume":"50","author":"BE Hogl","year":"1998","unstructured":"Hogl BE, Gomez-Arevalo G, Garcia S, et al.: A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson\u2019s disease. Neurology 1998, 50:1332\u20131339.","journal-title":"Neurology"},{"key":"41_CR69","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.870120608","volume":"12","author":"KR Chaudhuri","year":"1997","unstructured":"Chaudhuri KR, Ellis C, Love-Jones S, et al.: Postprandial hypotension and parkinsonian state in Parkinson\u2019s disease. Mov Disord 1997, 12:877\u2013884.","journal-title":"Mov Disord"},{"key":"41_CR70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(93)90633-V","volume":"157","author":"JJ Yang","year":"1993","unstructured":"Yang JJ, Lin MT: Arterial baroreceptor information affects striatal dopamine release measured by voltammetry in rats. Neurosci Lett 1993, 157:21\u201324.","journal-title":"Neurosci Lett"},{"key":"41_CR71","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","volume":"21","author":"J Wisor","year":"2001","unstructured":"Wisor J, Nishino S, Sora I, et al.: Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21:1787\u20131794.","journal-title":"J Neurosci"},{"key":"41_CR72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1520-6394(1998)7:2<92::AID-DA9>3.0.CO;2-7","volume":"7","author":"D Rye","year":"1998","unstructured":"Rye D, Dihenia B, Bliwise D: Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion. Depression Anxiety 1998, 7:92\u201395.","journal-title":"Depression Anxiety"},{"key":"41_CR73","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.34.8.1092","volume":"34","author":"C Goetz","year":"1984","unstructured":"Goetz C, Tanner C, Klawans H: Bupropion for Parkinson\u2019s disease. Neurology 1984, 34:1092\u20131094.","journal-title":"Neurology"},{"key":"41_CR74","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.102.039743","volume":"303","author":"M Hansard","year":"2002","unstructured":"Hansard M, Smith L, Jackson M, et al.: Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. J Pharmacol Exp Ther 2002, 303:952\u2013958.","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR75","first-page":"395","volume":"56","author":"J Ascher","year":"1995","unstructured":"Ascher J, Cole J, Colin JN, et al.: Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995, 56:395\u2013401.","journal-title":"J Clin Psychiatry"},{"key":"41_CR76","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.55.11.1732","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf I, Bejjani B, Garma L, et al.: Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55:1732\u20131734.","journal-title":"Neurology"},{"key":"41_CR77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.72.5.661","volume":"72","author":"A Iranzo","year":"2002","unstructured":"Iranzo A, Valldeoriola F, Santamaria J, et al.: Sleep symptoms and polysomnographic architecture in advanced Parkinson\u2019s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:661\u2013664.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"41_CR78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mds.10639","volume":"19","author":"N Hjort","year":"2004","unstructured":"Hjort N, Ostergaard K, Dupont E: Improvement of sleep quality in patients with advanced Parkinson\u2019s disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004, 19:196\u2013199.","journal-title":"Mov Disord"},{"key":"41_CR79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000050756","volume":"46","author":"L Lopiano","year":"2001","unstructured":"Lopiano L, Rizzone M, Bergamasco B, et al.: Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson\u2019s disease. European Neurol 2001, 46:49\u201350.","journal-title":"European Neurol"},{"key":"41_CR80","first-page":"591","volume":"26","author":"D Rye","year":"1997","unstructured":"Rye D, Dempsay J, Dihenia B, et al.: REM-sleep dyscontrol in Parkinson\u2019s disease: case report of effects of elective pallidotomy. Sleep Res 1997, 26:591.","journal-title":"Sleep Res"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-996-0041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-996-0041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-996-0041-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:28:42Z","timestamp":1559435322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-996-0041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s11910-996-0041-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}